Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of 10 citing Raymond: Oral thymic extract for chronic hepatitis C in patients previously treated with.... (0.09 sec) 

Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic …


J Liu, E Manheimer, K Tsutani, C Gluud - The American journal of …, 2003 - nature.com
Thirteen randomized trials (n = 818) evaluated 14 medicinal herbs. Four trials had adequate
methodology. Compared with placebo, none of the herbs showed effects on HCV RNA or liver
enzyme, except for silybin, which showed a significant reduction of serum AST and - ...
Cited by 88 - Related articles - BL Direct - All 15 versions

Complementary and alternative therapies in the treatment of chronic hepatitis C: a …


JT Coon, E Ernst - Journal of hepatology, 2004 - Elsevier
Twenty-seven eligible randomised clinical trials were located involving herbal products and
supplements. No randomised clinical trials were identified for any other complementary
therapy. In 14 of the trials, patients received interferon-α in combination with the ...
Cited by 43 - Related articles - All 9 versions

[CITATION] Complementary and alternative medicine in hepatitis C


DB STRADER, HJ ZIMMERMAN - Hepatitis C: Biomedical Research …, 2000 - Academic Pr
Cited by 9 - Related articles - All 2 versions

[PDF] Thymus Extracts: An International Literature Review of Clinical Studies


JL Wilson - Foundation for Immunology and Nutrition, development …, 1999 - hepatitiscfree.com
Maturation of T lymphocytes Historically, T lymphocytes mature in the thymus gland but we a
part of the myelopoietic cell line and have their origin in the bone marrow. As they develop, they
carry specific cell surface markers on the periphery of each cell which we used to identify ...
Cited by 3 - Related articles - View as HTML - All 17 versions

[CITATION] Last literature review version 17.1: Thu Jan 01 00: 00: 00 GMT 2009| This topic last …


… , TAATR FIBROSIS, TAATBHCV ENTRY, I CELLS
Related articles - All 2 versions

[CITATION] Investigational therapies for hepatitis C virus infection


HCVR MODELS, DOFC TREATMENTS, TTHCVE …
Related articles - All 2 versions

[CITATION] Investigational therapies for hepatitis C virus infection


… , TAATR FIBROSIS, TAATBHCV ENTRY, I CELLS
Related articles

[PDF] Tratamiento de las hepatitis virales crónicas B y C según la medicina basada en la …


D LEDRO, MG PARRA, MJ SÁENZ, D … - ANALES DE MEDICINA …, 2000 - SciELO Espana
En todo el mundo, la hepatitis aguda viral es la primera causa de enfermedad hepática aguda
y de ictericia. La hepati- tis crónica viral es la principal causa de cirrosis hepática y de
hepatocarcinoma. Importantes avances se han producido en el campo de la prevención ...
Related articles - View as HTML - All 2 versions

REVISIÓN DE CONJUNTO Tratamiento de las hepatitis virales crónicas B y C …


DL Cano, MG Parra, MJ Sáenz, DL Molina, … - An. Med. Interna ( …, 2000 - SciELO Espana
Ambas representan un porcentaje elevado de la etiología de las hepatitis virales y tienen una
alta tendencia a la cronicidad y al desarrollo de cirrosis, conllevando gran consumo de recursos
sanitarios. Por otra parte los tratamientos son prolongados y con fármacos de precio ...
Related articles - Cached - All 2 versions

Evidence-based medicine treatment of chronic viral hepatitis B and C


D Ledro Cano, M Gómez Parra, M Jiménez … - Anales de Medicina …, 2000 - SciELO Brasil
Related articles - Cached - All 2 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google